Figure 3.
Change in clinical outcome over a 20-year period. Histogram showing the clinical outcome as scored on the Glasgow Outcome Scale (GOS) in 1998–2002, 2006–2011, and 2012–2018. Score 5 indicates mild to no deficits (left), score 1 indicates death (right). Adjunctive dexamethasone was administered between 1992 and 2002 in 1/104 patients (1%), 0/2 patients (0%), 0/17 patients (0%), 1/48 patients (2%), and 9/165 patients (5%) from GOS 1 to 5, respectively, between 2006 and 2011 in 77/108 patients (71%), 1/1 patients (100%), 22/29 patients (76%), 87/104 patients (84%), and 305/352 patients (87%) from GOS 1 to 5 respectively, and between 2012 and 2018 in 100/141 patients (71%), 2/3 patients (67%), 33/44 patients (75%), 118/148 patients (80%), and 432/508 (85%) from GOS 1 to 5, respectively.